These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 17869522)

  • 21. Upregulated function of phosphatidylinositol-3-kinase in genetically hypertensive rats: a moderator of arterial hypercontractility.
    Northcott CA; Hayflick J; Watts SW
    Clin Exp Pharmacol Physiol; 2005 Oct; 32(10):851-8. PubMed ID: 16173947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Guareschi Pyridine Scaffold as a Valuable Platform for the Identification of Selective PI3K Inhibitors.
    Galli U; Ciraolo E; Massarotti A; Margaria JP; Sorba G; Hirsch E; Tron GC
    Molecules; 2015 Sep; 20(9):17275-87. PubMed ID: 26393561
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Isoform-selective inhibition of phosphoinositide 3-kinase: identification of a new region of nonconserved amino acids critical for p110α inhibition.
    Zheng Z; Amran SI; Thompson PE; Jennings IG
    Mol Pharmacol; 2011 Oct; 80(4):657-64. PubMed ID: 21778304
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production.
    Salh B; Wagey R; Marotta A; Tao JS; Pelech S
    J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based optimization of morpholino-triazines as PI3K and mTOR inhibitors.
    Poulsen A; Williams M; Nagaraj HM; William AD; Wang H; Soh CK; Xiong ZC; Dymock B
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1009-13. PubMed ID: 22197143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
    Rosenzweig KE; Youmell MB; Palayoor ST; Price BD
    Clin Cancer Res; 1997 Jul; 3(7):1149-56. PubMed ID: 9815794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Expression of phosphatidylinositol-3 kinase in epithelial ovarian carcinoma].
    Zhang PN; Sun H
    Zhonghua Fu Chan Ke Za Zhi; 2007 Mar; 42(3):196-200. PubMed ID: 17537308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LY294002 and rapamycin co-operate to inhibit T-cell proliferation.
    Breslin EM; White PC; Shore AM; Clement M; Brennan P
    Br J Pharmacol; 2005 Mar; 144(6):791-800. PubMed ID: 15778701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Class IA Phosphatidylinositol 3-Kinase Isoform p110α Mediates Vascular Remodeling.
    Vantler M; Jesus J; Leppänen O; Scherner M; Berghausen EM; Mustafov L; Chen X; Kramer T; Zierden M; Gerhardt M; Ten Freyhaus H; Blaschke F; Sterner-Kock A; Baldus S; Zhao JJ; Rosenkranz S
    Arterioscler Thromb Vasc Biol; 2015 Jun; 35(6):1434-44. PubMed ID: 25908763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A robust screen for inhibitors and enhancers of phosphoinositide-3 kinase (PI3K) activities by ratiometric fluorescence superquenching.
    Stankewicz C; Rininsland FH
    J Biomol Screen; 2006 Jun; 11(4):413-22. PubMed ID: 16490774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and Evaluation of Imidazo[1,2-a]pyridine Analogues of the ZSTK474 Class of Phosphatidylinositol 3-Kinase Inhibitors.
    Gamage SA; Spicer JA; Tsang KY; O'Connor PD; Flanagan JU; Lee WJ; Dickson JMJ; Shepherd PR; Denny WA; Rewcastle GW
    Chem Asian J; 2019 Apr; 14(8):1249-1261. PubMed ID: 30714356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant.
    Li T; Wang J; Wang X; Yang N; Chen SM; Tong LJ; Yang CH; Meng LH; Ding J
    J Pharmacol Exp Ther; 2010 Sep; 334(3):830-8. PubMed ID: 20522531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hemangiopoietin inhibits apoptosis of MO7e leukemia cells through phosphatidylinositol 3-kinase-AKT pathway.
    Zhan M; Han ZC
    Biochem Biophys Res Commun; 2004 Apr; 317(1):198-204. PubMed ID: 15047168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the kinetic properties of the lipid- and protein-kinase activities of the p110alpha and p110beta catalytic subunits of class-Ia phosphoinositide 3-kinases.
    Beeton CA; Chance EM; Foukas LC; Shepherd PR
    Biochem J; 2000 Sep; 350 Pt 2(Pt 2):353-9. PubMed ID: 10947948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of EGFR/PI3K/AKT cell survival pathway promotes TSA's effect on cell death and migration in human ovarian cancer cells.
    Zhou C; Qiu L; Sun Y; Healey S; Wanebo H; Kouttab N; Di W; Yan B; Wan Y
    Int J Oncol; 2006 Jul; 29(1):269-78. PubMed ID: 16773209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PI3K inhibitors block skeletogenesis but not patterning in sea urchin embryos.
    Bradham CA; Miranda EL; McClay DR
    Dev Dyn; 2004 Apr; 229(4):713-21. PubMed ID: 15042695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ.
    Collier PN; Messersmith D; Le Tiran A; Bandarage UK; Boucher C; Come J; Cottrell KM; Damagnez V; Doran JD; Griffith JP; Khare-Pandit S; Krueger EB; Ledeboer MW; Ledford B; Liao Y; Mahajan S; Moody CS; Roday S; Wang T; Xu J; Aronov AM
    J Med Chem; 2015 Jul; 58(14):5684-8. PubMed ID: 26121481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Liphagal, a Selective inhibitor of PI3 kinase alpha isolated from the sponge akacoralliphaga: structure elucidation and biomimetic synthesis.
    Marion F; Williams DE; Patrick BO; Hollander I; Mallon R; Kim SC; Roll DM; Feldberg L; Van Soest R; Andersen RJ
    Org Lett; 2006 Jan; 8(2):321-4. PubMed ID: 16408905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and PI3 Kinase Inhibition Activity of a Wortmannin-Leucine Derivative.
    Cantrell W; Huang Y; Menchaca AA; Kulik G; Welker ME
    Molecules; 2018 Jul; 23(7):. PubMed ID: 30036994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ErbB2-overexpressing human mammary carcinoma cells display an increased requirement for the phosphatidylinositol 3-kinase signaling pathway in anchorage-independent growth.
    Hermanto U; Zong CS; Wang LH
    Oncogene; 2001 Nov; 20(51):7551-62. PubMed ID: 11709727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.